CAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: Role of CPI-17

Cardiovascular Research

Volumn 87, Issue 2, 2010, Pages 375-384

  Aslam, Muhammad ^a   Härtel, Frauke V ^a   Arshad, Muhammad ^a   Gündüz, Dursun ^b   Abdallah, Yaser ^a   Sauer, Heinrich ^a   Piper, Hans Michael ^a   Noll, Thomas ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

CPI 17; Endothelial permeability; Epac; Myosin light chain phosphatase; PKA

Indexed keywords

8 (4 CHLOROPHENYLTHIO) 2' O METHYL CYCLIC AMP; ADENYLATE CYCLASE; CPI 17; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; FORSKOLIN; MYOSIN LIGHT CHAIN PHOSPHATASE; N6 BENZOYL CYCLIC AMP; PROTEIN INHIBITOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBIN; UNCLASSIFIED DRUG; 8-((4-CHLOROPHENYL)THIO)CYCLIC-3',5'-AMP; ENZYME ACTIVATOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MYOSIN LIGHT CHAIN; N(6)-BENZOYL-CYCLIC AMP; NUCLEOTIDE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PPP1R12A PROTEIN, HUMAN; PPP1R14A PROTEIN, HUMAN; RAPGEF3 PROTEIN, HUMAN; RHO KINASE; RHOA PROTEIN, HUMAN;

ARTICLE; CELL MEMBRANE PERMEABILITY; COMPLEX FORMATION; DEPHOSPHORYLATION; DOWN REGULATION; DRUG ANTAGONISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN; ANALOGS AND DERIVATIVES; CAPILLARY PERMEABILITY; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME;

ADENYLATE CYCLASE; CAPILLARY PERMEABILITY; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ENZYME ACTIVATORS; FORSKOLIN; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; THIONUCLEOTIDES; THROMBIN; TIME FACTORS; COLFORSIN;

EID: 77954323796     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq065     Document Type: Article

References (36)

1. Wysolmerski RB, Lagunoff D. Involvement of myosin light-chain kinase in endothelial cell retraction. Proc Natl Acad Sci USA 1990;87:16-20.
2. Schnittler HJ, Wilke A, Gress T, Suttorp N, Drenckhahn D. Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium. J Physiol 1990;431:379-401.
3. Goeckeler ZM, Wysolmerski RB. Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation. J Cell Biol 1995;130:613-627.
4. Garcia JG, Davis HW, Patterson CE. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 1995;163: 510-522.
5. Verin AD, Wang P, Garcia JG. Immunochemical characterization of myosin-specific phosphatase 1 regulatory subunits in bovine endothelium. J Cell Biochem 2000;76: 489-498.
6. Goeckeler ZM, Wysolmerski RB. Myosin phosphatase and cofilin mediate cAMP/cAMP-dependent protein kinase-induced decline in endothelial cell isometric tension and myosin II regulatory light chain phosphorylation. J Biol Chem 2005;280: 33083-33095.
7. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996; 273:245-248.
8. Senba S, Eto M, Yazawa M. Identification of trimeric myosin phosphatase (PP1M) as a target for a novel PKC-potentiated protein phosphatase-1 inhibitory protein (CPI17) in porcine aorta smooth muscle. J Biochem 1999;125:354-362.
9. Eto M, Senba S, Morita F, Yazawa M. Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 1997;410:356-360.
10. Härtel FV, Rodewald CW, Aslam M, Gündüz D, Hafer L, Neumann J et al. Extracellular ATP induces assembly and activation of the myosin light chain phosphatase complex in endothelial cells. Cardiovasc Res 2007;74:487-496.
11. Birukova AA, Smurova K, Birukov KG, Kaibuchi K, Garcia JG, Verin AD. Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvasc Res 2004;67:64-77.
12. Eto M, Kitazawa T, Matsuzawa F, Aikawa S, Kirkbride JA, Isozumi N et al. Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor. Structure 2007;15:1591-1602.
13. Sakai H, Hirano T, Takeyama H, Chiba Y, Misawa M. Acetylcholine-induced phos-phorylation of CPI-17 in rat bronchial smooth muscle: the roles of Rho-kinase and protein kinase C. Can J Physiol Pharmacol 2005;83:375-381.
14. Kolosova IA, Ma SF, Adyshev DM, Wang P, Ohba M, Natarajan V et al. Role of CPI-17 in the regulation of endothelial cytoskeleton. Am J Physiol Lung Cell Mol Physiol 2004; 287:L970-L980.
15. Gündüz D, Hirche F, Härtel FV, Rodewald CW, Schäfer M, Pfitzer G et al. ATP antagonism of thrombin-induced endothelial barrier permeability. Cardiovasc Res 2003;59: 470-478.
16. Bindewald K, Gündüz D, Härtel F, Peters SC, Rodewald C, Nau S et al. Opposite effect of cAMP signaling in endothelial barriers of different origin. Am J Physiol Cell Physiol 2004;287:C1246-C1255.
17. Langeler EG, van Hinsbergh VW. Norepinephrine and iloprost improve barrier function of human endothelial cell monolayers: role of cAMP. Am J Physiol 1991;260: C1052-C1059.
18. Essler M, Staddon JM, Weber PC, Aepfelbacher M. Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling. J Immunol 2000;164:6543-6549.
19. He P, Zeng M, Curry FE. Dominant role of cAMP in regulation of microvessel permeability. Am J Physiol Heart Circ Physiol 2000;278:H1124-H1133.
20. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998;396:474-477.
21. Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, Mayadas TN. Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 2005;105:1950-1955.
22. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N et al. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 2005;25:136-146.
23. Birukova AA, Zagranichnaya T, Fu P, Alekseeva E, Chen W, Jacobson JR et al. Prosta-glandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA-and Epac1/Rap1-dependent Rac activation. Exp Cell Res 2007;313:2504-2520.
24. Netherton SJ, Sutton JA, Wilson LS, Carter RL, Maurice DH. Both protein kinase A and exchange protein activated by cAMP coordinate adhesion of human vascular endothelial cells. Circ Res 2007;101:768-776.
25. Noll T, Wozniak G, McCarson K, Hajimohammad A, Metzner HJ, Inserte J et al. Effect of factor XIII on endothelial barrier function. J Exp Med 1999;189:1373-1382.
26. Christensen AE, Selheim F, de Rooij J, Dremier S, Schwede F, Dao KK et al. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J Biol Chem 2003;278:35394-35402.
27. Lum H, Jaffe HA, Schulz IT, Masood A, RayChaudhury A, Green RD. Expression of PKA inhibitor (PKI) gene abolishes cAMP-mediated protection to endothelial barrier dysfunction. Am J Physiol 1999;277:C580-C588.
28. Stelzner TJ, Weil JV, O'Brien RF. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J Cell Physiol 1989;139:157-166.
29. Patterson CE, Lum H, Schaphorst KL, Verin AD, Garcia JG. Regulation of endothelial barrier function by the cAMP-dependent protein kinase. Endothelium 2000;7: 287-308.
30. Pfeil U, Aslam M, Paddenberg R, Quanz K, Chang CL, Park JI et al. Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. Am J Physiol Lung Cell Mol Physiol 2009;297:L837-L845.
31. Sun H, Breslin JW, Zhu J, Yuan SY, Wu MH. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation 2006;13: 237-247.
32. Breslin JW, Yuan SY. Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability. Am J Physiol Heart Circ Physiol 2004;286:H1057-H1062.
33. Adamson RH, Curry FE, Adamson G, Liu B, Jiang Y, Aktories K et al. Rho and rho kinase modulation of barrier properties: cultured endothelial cells and intact micro-vessels of rats and mice. J Physiol 2002;539:295-308.
34. Adamson RH, Zeng M, Adamson GN, Lenz JF, Curry FE. PAF-and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction. Am J Physiol Heart Circ Physiol 2003;285:H406-H417.
35. Adamson RH, Ly JC, Sarai RK, Lenz JF, Altangerel A, Drenckhahn D et al. Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery. Am J Physiol Heart Circ Physiol 2008;294:H1188-H1196.
36. Göggel R, Uhlig S. The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema. Eur Respir J 2005;25:849-857.